Mallarino-Haeger Christina, Watson Allison, Mahgoub Umnia, Francis Lily, Heydari Maryam, Choudhary Muaaz, Garcia-Toca Manuel, Patel Manish, Kempker Russell R, Fayfman Maya, Schechter Marcos C
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Open Forum Infect Dis. 2024 Oct 11;11(11):ofae582. doi: 10.1093/ofid/ofae582. eCollection 2024 Nov.
Rifampin may improve diabetic foot osteomyelitis outcomes, but its extensive drug-drug interactions could hamper its use. Here, through a review of the medications prescribed to a cohort of 190 persons with diabetic foot osteomyelitis, we show that rifabutin, a rifamycin with fewer drug-drug interactions, would be easier to implement in practice.
利福平可能会改善糖尿病足骨髓炎的治疗效果,但其广泛的药物相互作用可能会妨碍其使用。在此,通过回顾190例糖尿病足骨髓炎患者所开具的药物,我们发现利福布汀(一种药物相互作用较少的利福霉素)在实际应用中更易于实施。